Delivery Order SPE2DB24D2010-SPE2DB25FAATR
Award Date 8/11/25
Potential Completion Date 8/12/25
Potential Value $3.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $8,215.15 to AmerisourceBergen Drug Corp for Orencia 125 mg/mL syringes on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Orencia (abatacept) is a biologic medication used primarily to treat rheumatoid arthritis and other autoimmune conditions,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes valued at $8,602.31 on September 2, 2025, with an ultimate completion date of September 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the major pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Orencia 125 mg/ml syringes valued at $20,773.97 on August 25, 2025, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Orencia 250 mg vials, valued at $4,283.82. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and is set to complete by July 25, 2025. Orencia (abatacept) is a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions, reflecting the agency's ongoing procurement of specialty pharmaceuticals to support military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ORENCIA 125 mg/ml syringes valued at $7,399.65 on August 19, 2025, with an ultimate completion date of August 20, 2025. This is a firm fixed price, non-set-aside contract with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a $11,893.95 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Orencia 125 mg/ml syringes. This non-set-aside competitive award is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency's Medical Supply Chain awarded a $7,236.05 delivery order to AmerisourceBergen Drug Corp for ORENCIA 125 mg/mL syringes under a firm fixed price contract type. This competitively awarded, non-set-aside delivery order was issued on July 31, 2025, with an ultimate completion date of August 1, 2025. ORENCIA (abatacept) is a biologic immunosuppressant medication used primarily to treat rheumatoid arthritis and other autoimmune conditions, representing a specialized...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,144.19 to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/ml on September 17, 2025, with an ultimate completion date of September 18, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. Orencia (abatacept) is a biologic immunosuppressant medication used to treat rheumatoid arthritis and other autoimmune...
- The Defense Logistics Agency awarded a delivery order valued at $3,748.72 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml on August 28, 2025, with an ultimate completion date of August 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Orencia (abatacept) is a biologic immunosuppressant medication used primarily in the treatment of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $32,445.94 to AmerisourceBergen Drug Corp for the supply of Orencia 125 mg/ml syringes. This competitive, firm fixed-price delivery order, with an ultimate completion date of August 21, 2025, was issued without set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills the order from its corporate office location in the same municipality. The...